Tokai Pharmaceuticals, Inc. IPO Research Information

Tokai Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Tokai Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Tokai Pharmaceuticals, Inc.	TKAI - NASDAQ	$13.00-$15.00	$15.00	$18.63	6.48 miillion	9/17/2014
Underwriter(s): BMO Capital Markets, Stifel, William Blair
Co-Manager(s): Janney Montgomery Scott
Industry: Health Care
Filing(s): Filed 2014-08-12 Terms Added 2014-09-02

Tokai Pharmaceuticals, Inc. Quote & Chart - Click for current quote - TKAI

About Tokai Pharmaceuticals, Inc. (adapted from Tokai Pharmaceuticals, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on developing novel proprietary therapies for the treatment of prostate cancer and other hormonally-driven diseases.

This description is adapted from Tokai Pharmaceuticals prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Tokai Pharmaceuticals "TKAI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.